In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Neumora Therapeutics Inc (NASDAQ: NMRA) was $10.63 for the day, down -4.41% from the previous closing price of $11.12. In other words, the price has decreased by -$4.41 from its previous closing price. On the day, 0.52 million shares were traded. NMRA stock price reached its highest trading level at $11.27 during the session, while it also had its lowest trading level at $10.4315.
Ratios:
Our analysis of NMRA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 10.98 and its Current Ratio is at 10.98. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on November 05, 2024, Downgraded its rating to Neutral and sets its target price to $15 from $18 previously.
On October 01, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.
On July 22, 2024, Needham started tracking the stock assigning a Buy rating and target price of $23.Needham initiated its Buy rating on July 22, 2024, with a $23 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 18 ’24 when Fust Matthew K sold 14,049 shares for $17.03 per share. The transaction valued at 239,319 led to the insider holds 20,100 shares of the business.
Fust Matthew K sold 7,739 shares of NMRA for $131,643 on Oct 17 ’24. The Director now owns 20,100 shares after completing the transaction at $17.01 per share. On Oct 18 ’24, another insider, Fust Matthew K, who serves as the Director of the company, bought 14,049 shares for $17.03 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 1717393408 and an Enterprise Value of 1368269056.
Stock Price History:
Over the past 52 weeks, NMRA has reached a high of $21.00, while it has fallen to a 52-week low of $8.33. The 50-Day Moving Average of the stock is -7.85%, while the 200-Day Moving Average is calculated to be -7.74%.
Shares Statistics:
NMRA traded an average of 1.09M shares per day over the past three months and 930110 shares per day over the past ten days. A total of 160.48M shares are outstanding, with a floating share count of 55.35M. Insiders hold about 65.74% of the company’s shares, while institutions hold 29.79% stake in the company. Shares short for NMRA as of 1732838400 were 10457148 with a Short Ratio of 9.92, compared to 1730332800 on 9367098. Therefore, it implies a Short% of Shares Outstanding of 10457148 and a Short% of Float of 12.24.
